These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Slim spoils for obesity drugs. Ledford H Nature; 2010 Dec; 468(7326):878. PubMed ID: 21164452 [No Abstract] [Full Text] [Related]
6. Lifestyle drug market booming. Atkinson T Nat Med; 2002 Sep; 8(9):909. PubMed ID: 12205440 [No Abstract] [Full Text] [Related]
7. [Drug therapy of obesity will come later]. Falkenberg M Lakartidningen; 1999 May; 96(21):2582-3. PubMed ID: 10388276 [No Abstract] [Full Text] [Related]
8. The pharmaceutical market for obesity therapies. Wong D; Sullivan K; Heap G Nat Rev Drug Discov; 2012 Sep; 11(9):669-70. PubMed ID: 22935797 [No Abstract] [Full Text] [Related]
9. A big issue? Marnell T Br J Gen Pract; 2006 Jan; 56(522):57. PubMed ID: 16438818 [No Abstract] [Full Text] [Related]
10. Anti-obesity drugs: are they worth it? Huntington MK; Shewmake RA Future Med Chem; 2011 Mar; 3(3):267-9. PubMed ID: 21446841 [No Abstract] [Full Text] [Related]
11. First in class, best in class or a wild card: who will dominate the anti-obesity medication market? Collins E; Beattie A; Ramagopalan SV; Pearson-Stuttard J J Comp Eff Res; 2024 Jul; 13(7):e240044. PubMed ID: 38808628 [No Abstract] [Full Text] [Related]
12. Diabetes and obesity: the twin epidemics. Smyth S; Heron A Nat Med; 2006 Jan; 12(1):75-80. PubMed ID: 16397575 [No Abstract] [Full Text] [Related]
15. Evaluation of soy hulls as a potential ingredient of functional foods for the prevention of obesity. Olguin MC; Posadas MD; Revelant GC; Labourdette VB; Elías HD; Venezia MR Ecol Food Nutr; 2010; 49(2):98-109. PubMed ID: 21883083 [TBL] [Abstract][Full Text] [Related]
16. Obesity--anything new? Walker AR S Afr Med J; 1997 May; 87(5):583-4. PubMed ID: 9254811 [No Abstract] [Full Text] [Related]
17. [Obesity and health economics. Review and status]. Pedersen KM; Worre-Jensen AL Ugeskr Laeger; 2006 Jan; 168(2):196-201. PubMed ID: 16403351 [TBL] [Abstract][Full Text] [Related]
18. National trends in the use and costs of anti-obesity medications in England 1998-2005. Srishanmuganathan J; Patel H; Car J; Majeed A J Public Health (Oxf); 2007 Jun; 29(2):199-202. PubMed ID: 17494061 [TBL] [Abstract][Full Text] [Related]
19. Obesity market overview. Farrigan C; Pang K Nat Rev Drug Discov; 2002 Apr; 1(4):257-8. PubMed ID: 12120276 [No Abstract] [Full Text] [Related]